Patents by Inventor Patrick John Thompson Vallance

Patrick John Thompson Vallance has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL USE
    Publication number: 20160067247
    Abstract: The present invention is directed to compounds or pharmaceutically acceptable salts thereof for use in the treatment of fibrotic diseases such as idiopathic pulmonary fibrosis (IPF).
    Type: Application
    Filed: November 18, 2015
    Publication date: March 10, 2016
    Inventors: Richard Francis WOOSTER, Pauline Teresa Lukey, Patrick John Thompson Vallance
  • PI3K INHIBITORS FOR TREATING FIBROTIC DISEASES
    Publication number: 20150051215
    Abstract: The present invention is directed to compounds or pharmaceutically acceptable salts thereof for use in the treatment of fibrotic diseases such as idiopathic pulmonary fibrosis (IPF).
    Type: Application
    Filed: February 4, 2013
    Publication date: February 19, 2015
    Inventors: Richard Francis Wooster, Pauline Teresa Lukey, Patrick John Thompson Vallance
  • Guanidine derivatives as inhibitors of DDAH
    Patent number: 8063104
    Abstract: Compounds of formula (I) have been found to be useful as inhibitors of DDAH.
    Type: Grant
    Filed: November 11, 2005
    Date of Patent: November 22, 2011
    Assignee: UCL Business PLC
    Inventors: Patrick John Thompson Vallance, James Mitchell Leiper, David Lawrence Selwood, Sharon Rossiter, Basil Hartzoulakis
  • GUANIDINE DERIVATIVES AS INHIBITORS OF DDAH
    Publication number: 20090069331
    Abstract: Compounds of formula (I) have been found to be useful as inhibitors of DDAH.
    Type: Application
    Filed: November 11, 2005
    Publication date: March 12, 2009
    Applicant: UCL Biomedica PLC c/o Finance Division University College of London
    Inventors: Patrick John Thompson Vallance, James Mitchell Leiper, David Lawrence Selwood, Sharon Rossiter, Basil Hartzoulakis
  • ASSAY FOR MEASURING ASYMMETRIC METHYLARGININE IN A BIOLOGICAL SAMPLE
    Publication number: 20090053741
    Abstract: The invention relates to a method of determining the presence and/or amount of an asymmetric methylarginine in a sample, the method comprising: (a) contacting the sample with a nitric oxide synthase (NOS) polypeptide in the presence of a detectably labelled species under conditions which permit the asymmetric methylarginine and detectably labelled species to bind to the NOS polypeptide; and (b) determining the amount or presence of the detectably labelled species bound to the NOS polypeptide
    Type: Application
    Filed: March 28, 2006
    Publication date: February 26, 2009
    Inventors: Patrick John Thompson Vallance, James Mitchell Leiper, David Edward Williams